Continuous glucose monitoring system(CGMS)

DEVICE2 trials

Sponsors

LG Chem, Yonsei University

Conditions

Type 1 DiabetesType 2 Diabetes Mellitus

Phase 4

Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)

CompletedNCT03202563

LG ChemType 2 Diabetes Mellitus

Start: 2017-08-09End: 2018-12-07Updated: 2019-02-15

Unknown Phase

The Management of Glucose Control and Hypoglycemic Prevention Using Continuous Glucose Monitoring System in Patients With Type 1 Diabetes

Yonsei UniversityType 1 Diabetes

Start: 2020-08-28End: 2022-08-31Target: 60Updated: 2021-05-06

Related Papers

1163-P: Comparison of Glycemic Variability between Gemigliptin and Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Randomized, Active-Controlled, Multicenter, 12-Week Clinical Trial (STABLE II Study)

Diabetes2019-06-01